These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18204420)

  • 1. The cysteinyl leukotrienes: where do they come from? What are they? Where are they going?
    Austen KF
    Nat Immunol; 2008 Feb; 9(2):113-5. PubMed ID: 18204420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
    Austen KF
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):182-7. PubMed ID: 17481553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cysteinyl leukotriene-induced contraction of human cultured bronchial smooth muscle cells.
    Kitamura N; Kaminuma O; Ohtomo T; Kiyokawa N; Kobayashi N; Suko M; Mori A
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():83-6. PubMed ID: 19494511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
    Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
    Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
    Parnes SM
    Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotrienes as mediators of airway obstruction.
    Drazen JM
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S193-200. PubMed ID: 9817745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mast cell and the cysteinyl leukotrienes.
    Austen KF
    Novartis Found Symp; 2005; 271():166-75; discussion 176-8, 198-9. PubMed ID: 16605134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of leukotrienes in airway inflammation.
    Ogawa Y; Calhoun WJ
    J Allergy Clin Immunol; 2006 Oct; 118(4):789-98; quiz 799-800. PubMed ID: 17030228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to cysteinyl-leukotriene receptors.
    Nicosia S; Capra V; Ravasi S; Rovati GE
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S46-50. PubMed ID: 10673226
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis.
    Ago H; Kanaoka Y; Irikura D; Lam BK; Shimamura T; Austen KF; Miyano M
    Nature; 2007 Aug; 448(7153):609-12. PubMed ID: 17632548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene modifiers in the treatment of cardiovascular diseases.
    Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
    J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.
    Norel X; Brink C
    Pharmacol Ther; 2004 Jul; 103(1):81-94. PubMed ID: 15251228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
    Ghosh A; Chen F; Thakur A; Hong H
    CNS Neurosci Ther; 2016 Dec; 22(12):943-951. PubMed ID: 27542570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma.
    Bizzintino JA; Khoo SK; Zhang G; Martin AC; Rueter K; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN; Hayden CM
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):9-15. PubMed ID: 19524426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cysteinyl leukotrienes and their receptors].
    Wódz-Naskiewicz K; Pawliczak R
    Postepy Biochem; 2009; 55(4):395-405. PubMed ID: 20201353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the understanding of leukotrienes in asthma.
    Coffey M; Peters-Golden M
    Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):57-63. PubMed ID: 12582316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.